Lobbying

  • Denver’s Revolving Door Hits Rush Hour: City Council Proposes 18‑Month Cooling‑Off Rule to Stall Former Officials from Lobbying

    ByPhil McCracken

    Denver’s City Council has decided it’s time to put some traffic lights on the well-trodden path connecting public office to private lobbying. They’ve floated a proposal to implement an 18-month cooling-off period meant to keep former city officials, including recent ex-Mayor Michael Hancock, from diving straight into lobbying gigs. A move like this is sure to leave some political shoes impatiently tapping in the waiting room.

    The overarching aim of this draft, as reported by Hoodline, is to cut down on the cozy handshakes between ex-officials and their newfound corporate clients. This proposal mandates lobbyists to disclose finer details like client payments, targeted officials, and grassroots spending over $5,000. It’s almost as if Denver’s demanding these disclosures wear their tax returns on their sleeves.

    Scheduled for its first hurdle on May 19 before the Community Planning & Housing Committee, the proposal needs some refinement before a full council vote expected in June. The scheme is not just a timestamped gate but a spotlight on where public virtue might slip between the pages of private billing.

    Critics, however, are waving the red flag of paperwork. They argue this transparency comes at a cost, putting undue burden on unpaid volunteers and grassroots groups—the folks who run on passion, not paychecks. Yet, it’s hard to ignore the reform’s echo in the wake of Hancock’s pivot to consulting, capitalizing on City Hall connections like a star quarterback signing endorsement checks.

    Presently, lobbyists file bi-monthly reports via the Clerk & Recorder’s SearchLight system, with public access that’s arguably more cloudy than illuminating. This reform is an attempt to hand Denver citizens a pair of glasses less fogged with bureaucratic haze.

    While Denver’s move might seem like a solo act, it’s caught in a national orchestra tuning up to similar notes. Yet, it’s important to remember this curtain isn’t down until June. Keep your eyes peeled to see if lobbyists brush up their dance moves or if civic groups harmonize for a different chorus.

    Sources

  • |

    When Better Math Equals Bigger Whining

    ByBrick Tungsten

    Folks, it seems like every time the good ol’ arithmetic around taxes sharpens up, those lobbyist types start wailing like they heard tofu was the new steak. You’d think we were threatening to confiscate their yachts instead of just tightening up economic forecasts with a sharper pencil. Improved math means shrinking loopholes, but it also means inflating a whole lot of lobbyist frustration. It’s a simple equation: the more accurate the math, the more dramatic the outcry. I’m all for a good barbecue debate, but if Betsy started yapping over better numbers, I’d consider her favorably marinated.

    See, I reckon it’s because when improved estimates show $87.7 billion in potential tax revenue, it gets mighty hot under the collars of those defending the wallet-openers. Nothing like watching folks scramble to find new shadows in the clear light of math. And there’s the rub, patriots: even when numbers get precise, some folks can’t resist trying to blur the facts when their wallets are involved. So, settle in with those grilled hot dogs while I remind you—the only thing impossible to barbecue is a lobbyist’s conscience.

  • |

    The Great Carried Interest Escape: How to Vanish Billionaires

    ByMoses Pray

    Brothers and sisters, gather ’round to witness the remarkable magic show taking place in the hallowed halls of Congress. Our wealthy friends, the performers in this act, have mastered the art of the grand disappearing act—threatening to whisk their fortunes abroad every time reform whispers its name at the door. The plot twist? They never actually pack a bag. No, the real vanishing act isn’t them—it’s the tax justice that mysteriously dissolves under a cloak of lobbying smoke.

    Now, let us pause in wonder: despite their dire warnings of a billionaire exodus reminiscent of an Old Testament retreat, those gilded patrons remain steadfastly in their mansions while our would-be reforms languish in the wilderness. Perhaps it’s time we recognize that this isn’t a battle of economics, but a spectacle of power where sleight of hand ensures that the only thing disappearing is our shared sense of financial fairness. Peace be with those who still believe that wealth will one day lose its ability to pull the wool over our eyes.

  • |

    Defense Contractors Quietly Buying Influence on the NDAA Through PAC Dollars

    ByPhil McCracken

    The unmistakable aroma of lobbyist cologne wafts through Capitol Hill corridors as defense contractors discreetly funnel nearly $5 million into the pockets of key lawmakers. According to a Defense News report, these contributions from PACs and individuals in the defense sector are squarely aimed at the architects of the National Defense Authorization Act (NDAA). It’s a well-rehearsed dance where money whispers louder than constituent voices.

    Let’s talk numbers. Congressmen Rep. Ken Calvert, Rep. Adam Smith, and Rep. Mike Rogers lead the parade, collecting sums that could make a lottery winner blush—around $200,000, $130,000, and $68,000, respectively. Notably, Rogers’ campaign fund got a $7,000 cherry on top from Palmer Luckey, the defense-tech mogul known for making virtual realities a bit too real.

    Why should you care about these cash flows? Because they’re greasing the skids for legislation like the SPEED Act, which seeks to put defense acquisition on a deregulation fast track. It’s a roadmap to less oversight, leaving procurement as transparent as a poker player’s bluff.

    Rep. Brian Mast lent his hand to the legislative potluck with a proposal linking loans to foreign arms sales. It’s a recipe intentionally seasoned to benefit those holding the wallet strings. Meanwhile, oversight retreats faster than a beleaguered mascot on a slippery stadium field. The Department of Defense Inspector General’s audits have spotlighted contractor overbilling; yet here we are, ready to tear down what little scrutiny remains.

    The risks are real. We’re talking about service members potentially equipped with weapons put together under the philosophy of ‘good enough,’ all while taxpayers shoulder the bloated invoices. The Office of the Director, Operational Test and Evaluation (DOT&E) waves the caution flag, warning of what could happen if oversight continues its disappearing act.

    So, taxpayers, grab your calculators. This isn’t just a Capitol Hill shuffle; it’s your money playing duck-and-cover in a game of political influence. When private cash pries open public wallets, you have to wonder who’s getting a bargain—and who’s getting swindled.

    In this murky tale of influence-peddling, the moral remains clear though obscure—the invoice has been signed and stamped, but did anyone bother to read the fine print?

    Sources

  • |

    Crypto-Backed PAC Falls Short of $100M Claims—Spends Big with Tether-Linked Firm

    ByPhil McCracken

    In a world where big claims often come with small receipts, Fellowship PAC has announced a modest $11 million in contributions, leaving the $100 million it once boasted about as elusive as a polite cab ride in a rainstorm. Yet, the one move they didn’t skimp on? Sending a cool $3 million to a firm co-founded by Tether US’s CEO, Bo Hines, for an ad buy that smells suspiciously like lobbyist cologne.

    This isn’t just a numbers game; it’s a peek into how what looked like a $100 million mileage turned into one with more broken odometers than a clunker dealership. The Federal Election Commission (FEC) filings revealed $10 million came from Cantor Fitzgerald and $1 million from Anchorage Digital—ironic, considering we were promised a crypto gold rush at the PAC’s launch event last September, which seems to have been a mirage in reverse.

    For those keeping score at home, a healthy chunk of that wallet went to Nxum Group for issue advocacy ads, a firm with Bo Hines, a familiar face from Tether, in the driver’s seat. Let’s call it a comfort zone spend, touching base with a fellow expatriate from the land of crypto volatility.

    Why should the average citizen care about a PAC’s balance sheet that reads like a bad accounting joke? Well, the ties between Cantor Fitzgerald and Tether could make any public treasury watchdog twitchy. As Tether’s fiscal shadow looms large, the stakes for pay-to-play optics have never been higher. It’s the kind of thing that gives campaign finance a revolving door that even doorway enthusiasts would admire.

    The underside of these figures is a lesson in vendor access where the purse strings are snagged by financial Goliaths rather than the crypto enthusiasts rooting in the blockchain bleachers. But to wrap it all up, remember folks, in the world of political finance: public virtue often takes a back seat, leaving private mileage and insider deals to fill the tank.

    Sources

  • |

    PhRMA’s Seven-Figure 340B Ad Blitz vs. TrumpRx Lobbying Surge

    ByPhil McCracken

    PhRMA isn’t playing coy. Earlier this month, they rolled out a seven-figure ad campaign targeting the 340B drug discount program, branding it as a cozy corner for hospital exploitation. On the surface: a public service announcement in slick-suit attire. Behind the curtain, though, the same outfit was pouring $12.2 million in Q1 2026 into lobbying efforts—ranking as one of the trade group’s heftiest checks ever written in a quarter, according to Bloomberg Law.

    The paradox here would amuse a cat. While television screens flash with moral indignation over discounted meds for clinics serving the underprivileged, PhRMA’s lobbyists are busy weaving legislative webs in Capitol Hill hallways. If talk is cheap, lobbying clearly doesn’t get the same discount—more like champagne on a shoe-string cut price.

    Here’s the kicker: PhRMA isn’t isolated on this spending spree. As reported by the Sacramento Bee, pharmaceutical companies tied to the TrumpRx initiative shelled out over $130 million in 2025, marking a 23% increase in their lobbying efforts. The narrative is clear: while projecting a wholesome PSA vibe against drug discounts, Big Pharma is wrapping Capitol Hill in a cashmere blanket of influence.

    The 340B program, designed to enable hospitals and clinics to provide affordable meds to needy patients, has been a thorn in PhRMA’s side for a while. They argue the rebates are a windfall for hospitals rather than a direct benefit for patients. You could say it’s a bit like suggesting the hospital uses the program’s ‘gains’ to sneak an espresso machine into the break room.

    Then there’s TrumpRx, a program ostensibly crafted to curb soaring drug prices. Its partners’ heightened lobby spend tells a different story: ensuring the policymaking process is as friendly as a longtime poker buddy.

    The juxtaposition is almost laughable: the louder the commercials, the fatter the lobbying invoices. Public outrage serves as the shiny distraction while the private billing department hums its quiet tune, and yet, who’s footing the bill? Not the executive who’s likely enjoying a cafe’s worth of gratis macchiatos—but rather taxpayers, indirectly contributing to this financial ballet.

    Keep your eyes peeled; as these ad campaigns echo on, the Q2 lobbying disclosures are bound to deliver another round of intrigue—and perhaps, a few more giggles from those tracking lobbyist cologne and receipt trails.

    Sources

End of content

End of content